Home
Glaxosmithkline Pharmaceuticals Ltd
GLAXO Share Price
BSE:
NSE:GLAXO
GLAXO Share Price
BSE:
NSE:GLAXO
Pharmaceuticals
Large Cap
₹-
0 (0%)
Market Cap
₹40,269.51 Cr
PE Ratio
50.22
Glaxosmithkline Pharmaceuticals Ltd Performance
▲
▲
▲
▲
Glaxosmithkline Pharmaceuticals Ltd Fundamentals
Glaxosmithkline Pharmaceuticals Ltd Delivery and Volume
GLAXO Investment Return
Loading...
GLAXO Revenue Growth
About Glaxosmithkline Pharmaceuticals Ltd
GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of UK-based GSK Plc., a global biopharma company to unite science, technology and talent to get ahead of disease together. The Company is headquartered in Mumbai and it has six branch offices, a manufacturing facility at Nashik in Maharashtra,
| Name | Designation |
|---|---|
| D Sundaram | Independent Director |
| A A Nadkarni | Company Sec. & Compli. Officer |
| P V Bhide | Independent Director |
| A N Roy | Independent Director |
| Subesh Williams | Non Executive Director |
| Renu S Karnad | Chairperson |
| Sunita Maheshwari | Independent Director |
| Manu Anand | Independent Director |
| Bhushan Akshikar | Managing Director |
| J. Chandy | Whole Time Director & CFO |
News and Events...
Similar Stocks
Top Mutual Funds Invested in GLAXO
Top Gainers Today
View All
Top Losers Today
View All
Glaxosmithkline Pharmaceuticals Ltd FAQs
How do I Buy Glaxosmithkline Pharmaceuticals Ltd Shares?
By opening a demat account and having your KYC papers confirmed online, you may simply purchase Glaxosmithkline Pharmaceuticals Ltd shares in BlinkX.
What is the Share Price of Glaxosmithkline Pharmaceuticals Ltd?
The share price of any stock is volatile and changes during the day due to a variety of variables. Glaxosmithkline Pharmaceuticals Ltd's share price is ₹2381.2 as of 2024-12-05.
What is the PE ratio of Glaxosmithkline Pharmaceuticals Ltd?
Glaxosmithkline Pharmaceuticals Ltd's P/E ratio is 50.22 times as of 2024-12-05.
What is the PB ratio of Glaxosmithkline Pharmaceuticals Ltd?
Glaxosmithkline Pharmaceuticals Ltd's most recent financial reports indicate a price-to-book ratio of 24.07, showing the company's stock market valuation in relation to the value of its real assets.
What is the Market Cap of Glaxosmithkline Pharmaceuticals Ltd?
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Glaxosmithkline Pharmaceuticals Ltd's market capitalization is ₹40269.51 Cr as on 2024-12-05.
What is the ROE of Glaxosmithkline Pharmaceuticals Ltd?
The current financial records of Glaxosmithkline Pharmaceuticals Ltd show a 36.83% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
What is the Total Asset of Glaxosmithkline Pharmaceuticals Ltd?
According to Glaxosmithkline Pharmaceuticals Ltd's most recent financial filings, the company has a total asset value of ₹2115.7, which includes current and non-current assets such as inventory, cash, properties, and equipment.
What is the 52-week high and Low of Glaxosmithkline Pharmaceuticals Ltd?
The 52-week high/low price of a Glaxosmithkline Pharmaceuticals Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Glaxosmithkline Pharmaceuticals Ltd's 52-week high and low as of 2024-12-05 are ₹2407.8 and ₹2361, respectively.
